Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Breast 2Thoracic 1Gynecologic 1Genitourinary 1

Conditions

Endometrial Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Motor Activity 1Colorectal Neoplasms 1Colonic Neoplasms 1Behavior 1

Interventions

pembrolizumab 8Oxaliplatin 7Surveys and Questionnaires 5Methods 5Early Intervention, Educational 5Cyclophosphamide 5Cisplatin 5Paclitaxel 4Magnetic Resonance Spectroscopy 4Leucovorin 4Gemcitabine 4Fluorouracil 4Carboplatin 4veliparib 3aldesleukin 3Trastuzumab 3Specimen Handling 3Nivolumab 3Diathermy 3Cytoreduction Surgical Procedures 3sargramostim 2entinostat 2cemiplimab 2cediranib 2X-Rays 2Therapeutics 2Radiotherapy 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Metformin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Neoplasms × Motivational Interviewing × Gynecologic × Clear all
NCT03210129 2019-03-14

MIPAClux

Luxembourg Institute of Health

Phase NA Completed
25 enrolled
BreastGastrointestinalGynecologic

Behavior, Breast Neoplasms, Colonic Neoplasms, Motor Activity, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡